HEADER ALLERGEN 05-JUL-07 2QIM TITLE CRYSTAL STRUCTURE OF PATHOGENESIS-RELATED PROTEIN LLPR-10.2B FROM TITLE 2 YELLOW LUPINE IN COMPLEX WITH CYTOKININ COMPND MOL_ID: 1; COMPND 2 MOLECULE: PR10.2B; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CLASS 10 PLANT PATHOGENESIS-RELATED PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LUPINUS LUTEUS; SOURCE 3 ORGANISM_COMMON: YELLOW LUPINE; SOURCE 4 ORGANISM_TAXID: 3873; SOURCE 5 GENE: PR10.2B, YPR10.2B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET3A KEYWDS TRANS-ZEATIN, CYTOKININ, PLANT HORMONES, PLANT PROTEIN, PR-10 KEYWDS 2 PROTEIN, PATHOGENESIS-RELATED PROTEIN, ALLERGEN EXPDTA X-RAY DIFFRACTION AUTHOR H.C.FERNANDES,O.PASTERNAK,G.BUJACZ,A.BUJACZ,M.M.SIKORSKI,M.JASKOLSKI REVDAT 6 03-APR-24 2QIM 1 REMARK REVDAT 5 21-FEB-24 2QIM 1 REMARK REVDAT 4 13-JUL-11 2QIM 1 VERSN REVDAT 3 24-FEB-09 2QIM 1 VERSN REVDAT 2 13-MAY-08 2QIM 1 JRNL REVDAT 1 29-APR-08 2QIM 0 JRNL AUTH H.FERNANDES,O.PASTERNAK,G.BUJACZ,A.BUJACZ,M.M.SIKORSKI, JRNL AUTH 2 M.JASKOLSKI JRNL TITL LUPINUS LUTEUS PATHOGENESIS-RELATED PROTEIN AS A RESERVOIR JRNL TITL 2 FOR CYTOKININ. JRNL REF J.MOL.BIOL. V. 378 1040 2008 JRNL REFN ISSN 0022-2836 JRNL PMID 18406424 JRNL DOI 10.1016/J.JMB.2008.03.027 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH O.PASTERNAK,J.BIESIADKA,R.DOLOT,L.HANDSCHUH,G.BUJACZ, REMARK 1 AUTH 2 M.M.SIKORSKI,M.JASKOLSKI REMARK 1 TITL STRUCTURE OF A YELLOW LUPIN PATHOGENESIS-RELATED PR-10 REMARK 1 TITL 2 PROTEIN BELONGING TO A NOVEL SUBCLASS REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 61 99 2005 REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 15608381 REMARK 1 DOI 10.1107/S0907444904028173 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.BIESIADKA,G.BUJACZ,M.M.SIKORSKI,M.JASKOLSKI REMARK 1 TITL CRYSTAL STRUCTURES OF TWO HOMOLOGOUS PATHOGENESIS-RELATED REMARK 1 TITL 2 PROTEINS FROM YELLOW LUPINE REMARK 1 REF J.MOL.BIOL. V. 319 1223 2002 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 12079359 REMARK 1 DOI 10.1016/S0022-2836(02)00385-6 REMARK 1 REFERENCE 3 REMARK 1 AUTH O.PASTERNAK,G.D.BUJACZ,Y.FUJIMOTO,Y.HASHIMOTO,F.JELEN, REMARK 1 AUTH 2 J.OTLEWSKI,M.M.SIKORSKI,M.JASKOLSKI REMARK 1 TITL CRYSTAL STRUCTURE OF VIGNA RADIATA CYTOKININ-SPECIFIC REMARK 1 TITL 2 BINDING PROTEIN IN COMPLEX WITH ZEATIN REMARK 1 REF PLANT CELL V. 18 2622 2006 REMARK 1 REFN ISSN 1040-4651 REMARK 1 PMID 16998071 REMARK 1 DOI 10.1105/TPC.105.037119 REMARK 1 REFERENCE 4 REMARK 1 AUTH M.GAJHEDE,P.OSMARK,F.M.POULSEN,H.IPSEN,J.N.LARSEN, REMARK 1 AUTH 2 R.J.JOOST VAN NEERVEN,C.SCHOU,H.LOWENSTEIN,M.D.SPANGFORT REMARK 1 TITL X-RAY AND NMR STRUCTURE OF BET V 1, THE ORIGIN OF BIRCH REMARK 1 TITL 2 POLLEN ALLERGY REMARK 1 REF NAT.STRUCT.BIOL. V. 3 1040 1996 REMARK 1 REFN ISSN 1072-8368 REMARK 1 PMID 8946858 REMARK 1 DOI 10.1038/NSB1296-1040 REMARK 1 REFERENCE 5 REMARK 1 AUTH Z.MARKOVIC-HOUSLEY,M.DEGANO,D.LAMBA,E.VON ROEPENACK-LAHAYE, REMARK 1 AUTH 2 S.CLEMENS,M.SUSANI,F.FERREIRA,O.SCHEINER,H.BREITENEDER REMARK 1 TITL CRYSTAL STRUCTURE OF A HYPOALLERGENIC ISOFORM OF THE MAJOR REMARK 1 TITL 2 BIRCH POLLEN ALLERGEN BET V 1 AND ITS LIKELY BIOLOGICAL REMARK 1 TITL 3 FUNCTION AS A PLANT STEROID CARRIER. REMARK 1 REF J.MOL.BIOL. V. 325 123 2003 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 12473456 REMARK 1 DOI 10.1016/S0022-2836(02)01197-X REMARK 2 REMARK 2 RESOLUTION. 1.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 44481 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.148 REMARK 3 R VALUE (WORKING SET) : 0.147 REMARK 3 FREE R VALUE : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.500 REMARK 3 FREE R VALUE TEST SET COUNT : 1163 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.35 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.39 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3271 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.2160 REMARK 3 BIN FREE R VALUE SET COUNT : 84 REMARK 3 BIN FREE R VALUE : 0.2870 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1184 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 71 REMARK 3 SOLVENT ATOMS : 233 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.22 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.37000 REMARK 3 B22 (A**2) : -0.37000 REMARK 3 B33 (A**2) : 0.55000 REMARK 3 B12 (A**2) : -0.18000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.044 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.049 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.030 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.642 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.975 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.961 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1304 ; 0.020 ; 0.024 REMARK 3 BOND LENGTHS OTHERS (A): 825 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1761 ; 2.043 ; 2.332 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2052 ; 0.960 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 156 ; 5.844 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 52 ;41.155 ;26.731 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 220 ;11.498 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 1 ; 0.408 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 195 ; 0.112 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1425 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 216 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 257 ; 0.215 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 783 ; 0.190 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 643 ; 0.194 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 696 ; 0.089 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 162 ; 0.192 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 4 ; 0.152 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 5 ; 0.102 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 21 ; 0.151 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 18 ; 0.146 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 801 ; 5.053 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 325 ; 3.893 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1264 ; 6.031 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 588 ; 9.167 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 497 ;11.702 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 2328 ; 4.477 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 234 ;24.169 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 2106 ;11.390 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 157 REMARK 3 ORIGIN FOR THE GROUP (A): 63.4287 48.9393 0.2718 REMARK 3 T TENSOR REMARK 3 T11: 0.0262 T22: 0.0238 REMARK 3 T33: 0.0191 T12: -0.0005 REMARK 3 T13: -0.0049 T23: 0.0031 REMARK 3 L TENSOR REMARK 3 L11: 0.0783 L22: 0.1320 REMARK 3 L33: 0.0949 L12: 0.0484 REMARK 3 L13: 0.0043 L23: -0.0309 REMARK 3 S TENSOR REMARK 3 S11: 0.0026 S12: -0.0006 S13: 0.0112 REMARK 3 S21: -0.0133 S22: 0.0074 S23: 0.0250 REMARK 3 S31: 0.0054 S32: 0.0069 S33: -0.0100 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2QIM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JUL-07. REMARK 100 THE DEPOSITION ID IS D_1000043644. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JAN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8030 REMARK 200 MONOCHROMATOR : SI[111], HORIZONTALLY FOCUSSING REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45644 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.350 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 9.700 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 56.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.10 REMARK 200 R MERGE FOR SHELL (I) : 0.67000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: LLPR-10.2F REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.2 M SODIUM CITRATE, 0.1 M MES PH REMARK 280 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.80800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 22.40400 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 33.60600 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 11.20200 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 56.01000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 27 CB - CG - OD1 ANGL. DEV. = 6.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 23 -75.10 -116.39 REMARK 500 ASP A 92 -144.06 -127.93 REMARK 500 TYR A 156 154.46 177.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 158 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZEA A 159 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZEA A 160 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZEA A 161 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZEA A 162 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 163 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XDF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PATHOGENESIS-RELATED PROTEIN LLPR-10.2A FROM REMARK 900 YELLOW LUPINE REMARK 900 RELATED ID: 1ICX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PATHOGENESIS-RELATED PROTEIN LLPR-10.1A FROM REMARK 900 YELLOW LUPIN REMARK 900 RELATED ID: 1IFV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PATHOGENESIS-RELATED PROTEIN LLPR-10.1B FROM REMARK 900 YELLOW LUPINE REMARK 900 RELATED ID: 2FLH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYTOKININ-SPECIFIC BINDING PROTEIN FROM MUNG REMARK 900 BEAN IN COMPLEX WITH CYTOKININ REMARK 900 RELATED ID: 1BV1 RELATED DB: PDB REMARK 900 BIRCH POLLEN ALLERGEN BET V 1 REMARK 900 RELATED ID: 1FM4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE BIRCH POLLEN ALLERGEN BET V 1L REMARK 900 RELATED ID: 1E09 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE MAJOR CHERRY ALLERGEN PRU AV 1 DBREF 2QIM A 0 157 UNP Q9LLQ2 Q9LLQ2_LUPLU 1 158 SEQRES 1 A 158 MET GLY VAL PHE THR PHE GLN ASP GLU TYR THR SER THR SEQRES 2 A 158 ILE ALA PRO ALA LYS LEU TYR LYS ALA LEU VAL THR ASP SEQRES 3 A 158 ALA ASP ILE ILE ILE PRO LYS ALA VAL GLU THR ILE GLN SEQRES 4 A 158 SER VAL GLU ILE VAL GLU GLY ASN GLY GLY PRO GLY THR SEQRES 5 A 158 ILE LYS LYS LEU THR PHE ILE GLU GLY GLY GLU SER LYS SEQRES 6 A 158 TYR VAL LEU HIS LYS ILE GLU ALA ILE ASP GLU ALA ASN SEQRES 7 A 158 LEU GLY TYR ASN TYR SER ILE VAL GLY GLY VAL GLY LEU SEQRES 8 A 158 PRO ASP THR ILE GLU LYS ILE SER PHE GLU THR LYS LEU SEQRES 9 A 158 VAL GLU GLY ALA ASN GLY GLY SER ILE GLY LYS VAL THR SEQRES 10 A 158 ILE LYS ILE GLU THR LYS GLY ASP ALA GLN PRO ASN GLU SEQRES 11 A 158 GLU GLU GLY LYS ALA ALA LYS ALA ARG GLY ASP ALA PHE SEQRES 12 A 158 PHE LYS ALA ILE GLU SER TYR LEU SER ALA HIS PRO ASP SEQRES 13 A 158 TYR ASN HET CA A 158 1 HET ZEA A 159 16 HET ZEA A 160 16 HET ZEA A 161 16 HET ZEA A 162 16 HET GOL A 163 6 HETNAM CA CALCIUM ION HETNAM ZEA (2E)-2-METHYL-4-(9H-PURIN-6-YLAMINO)BUT-2-EN-1-OL HETNAM GOL GLYCEROL HETSYN ZEA TRANS-ZEATIN HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 CA CA 2+ FORMUL 3 ZEA 4(C10 H13 N5 O) FORMUL 7 GOL C3 H8 O3 FORMUL 8 HOH *233(H2 O) HELIX 1 1 ALA A 14 VAL A 23 1 10 HELIX 2 2 ASP A 25 VAL A 34 1 10 HELIX 3 3 GLU A 75 ASN A 77 5 3 HELIX 4 4 ASN A 128 HIS A 153 1 26 SHEET 1 A 7 VAL A 2 SER A 11 0 SHEET 2 A 7 SER A 111 THR A 121 -1 O GLY A 113 N TYR A 9 SHEET 3 A 7 ILE A 94 GLU A 105 -1 N LYS A 102 O LYS A 114 SHEET 4 A 7 GLY A 79 GLY A 87 -1 N TYR A 82 O PHE A 99 SHEET 5 A 7 GLU A 62 ASP A 74 -1 N ALA A 72 O ASN A 81 SHEET 6 A 7 ILE A 52 GLU A 59 -1 N LEU A 55 O VAL A 66 SHEET 7 A 7 ILE A 37 GLU A 44 -1 N GLU A 41 O LYS A 54 SITE 1 AC1 5 PRO A 31 ILE A 37 HOH A 183 HOH A 247 SITE 2 AC1 5 HOH A 260 SITE 1 AC2 9 ILE A 30 HIS A 68 TYR A 80 TYR A 82 SITE 2 AC2 9 THR A 101 PHE A 143 HOH A 170 HOH A 176 SITE 3 AC2 9 HOH A 181 SITE 1 AC3 9 ASP A 7 TYR A 9 TYR A 82 PHE A 99 SITE 2 AC3 9 ILE A 117 ALA A 135 HOH A 164 HOH A 174 SITE 3 AC3 9 HOH A 175 SITE 1 AC4 10 PHE A 57 GLU A 59 ARG A 138 GLY A 139 SITE 2 AC4 10 HOH A 167 HOH A 168 HOH A 173 HOH A 211 SITE 3 AC4 10 HOH A 213 HOH A 242 SITE 1 AC5 10 PHE A 5 GLN A 6 ASP A 7 ILE A 52 SITE 2 AC5 10 LYS A 54 GLU A 129 LYS A 133 HOH A 275 SITE 3 AC5 10 HOH A 281 HOH A 291 SITE 1 AC6 3 ALA A 152 HOH A 319 HOH A 331 CRYST1 73.822 73.822 67.212 90.00 90.00 120.00 P 65 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013546 0.007821 0.000000 0.00000 SCALE2 0.000000 0.015642 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014878 0.00000